Pulmonx is the developer of the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema.
For more details on financing and valuation for Pulmonx, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
LUNG
12 as of 3/20/23
To read this article and more news on Pulmonx, register or login.